Nutrabiotix, LLC Report issue

For profit Phase 2
Founded: West Lafayette IN United States (2007)
Status: Defunct (2017)

Organization Overview

First Clinical Trial
2014
NCT02144753
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

ntx-1 (1 trial)

psyllium (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Constipation (Phase 2)

Irritable Bowel Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2